anthropogenic < anti < antibacterial

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 81.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000014 (1998)	A. Natali [Italie] ; E. Pilotti [Italie] ; P. O. Valcavi [Italie] ; C. Chezzi [Italie] ; J. S. Oxford [Royaume-Uni]	Natural and ‘ In vitro ’ selected antigenic variants of influenza A virus (H2N2)
000084 (2000)	J. S. Oxford [Royaume-Uni]	Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology
000097 (1999)	Antonios Kolocouris [Grèce] ; Dimitrios Tataridis [Grèce] ; George Fytas [Grèce] ; Thomas Mavromoustakos [Grèce] ; George B. Foscolos [Grèce] ; Nicolas Kolocouris [Grèce] ; Erik De Clercq [Belgique]	Synthesis of 2-(2-adamantyl)piperidines and structure anti-influenza virus a activity relationship study using a combination of NMR spectroscopy and molecular modeling
000143 (2009)	Seyyed Mahmoud Ebrahimi [Iran] ; Majid Tebianian [Iran] ; Khosrow Aghaiypour [Iran] ; Hassan Nili [Iran] ; Ali Mirjalili [Iran]	Prokaryotic expression and characterization of avian influenza A virus M2 gene as a candidate for universal recombinant vaccine against influenza A subtypes; specially H5N1 and H9N2
000175 (2001)	Christoph Scholtissek [États-Unis] ; Jurgen Stech [États-Unis] ; Scott Krauss [États-Unis] ; Robert G. Webster [États-Unis]	Compatibility of various avian HA subtypes with the genome of human influenza A viruses
000197 (1998)	Daisei Miyamoto [Japon] ; Yuki Kusagaya [Japon] ; Naoko Endo [Japon] ; Ayako Sometani [Japon] ; Seiji Takeo [Japon] ; Takashi Suzuki [Japon] ; Yaeno Arima [Japon] ; Katsuyuki Nakajima [États-Unis] ; Yasuo Suzuki [Japon]	Thujaplicin–copper chelates inhibit replication of human influenza viruses
000199 (1995)	I. A. Leneva [Russie] ; N. I. Fadeeva [Russie] ; I. T. Fedyakina [Russie] ; T. A. Gus'Kova [Russie] ; N. L. Khristova [Russie] ; M. V. Sokolova [Russie] ; I. G. Kharitonenkov [Russie]	Use of enzyme immunoassay to identify virus-specific antigens in studying a new anti-influenza preparation, arbidol
000214 (2004)	Hiroshi Kido [Japon] ; Yuushi Okumura [Japon] ; Hiroshi Yamada [Japon] ; Dai Mizuno [Japon] ; Youichirou Higashi [Japon] ; Mihiro Yano [Japon]	Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential
000223 (1994)	Yan Wu [États-Unis] ; Yang Liu [États-Unis]	Viral induction of co-stimulatory activity on antigen-presenting cells bypasses the need for CD4+ T-cell help in CD8+ T-cell responses
000232 (1990)	Frederick G. Hayden [États-Unis, Royaume-Uni] ; Barbara S. Rollins [États-Unis, Royaume-Uni] ; Alan J. Hay [États-Unis, Royaume-Uni]	Anti-influenza virus activity of the compound LY253963
000244 (1998)	Christoph Scholtissek [États-Unis] ; Robert G. Webster [États-Unis]	Long-term stability of the anti-influenza A compounds—amantadine and rimantadine
000249 (1999)	J. Yoshimoto [Japon] ; M. Kakui [Japon] ; H. Iwasaki [Japon] ; T. Fujiwara [Japon] ; H. Sugimoto [Japon] ; N. Hattori [Japon]	Identification of a novel HA conformational change inhibitor of human influenza virus
000265 (1995)	M. Aymard [France] ; M. F. Odelin [France] ; J. Million-Jolly [France]	Immunité antigrippale
000291 (1998)	K. Noma [Japon] ; K. Kiyotani [Japon] ; H. Kouchi [Japon] ; Y. Fujii [Japon] ; Y. Egi [Japon] ; K. Tanaka [Japon] ; T. Yoshida [Japon]	Endogenous protease-dependent replication of human influenza viruses in two MDCK cell lines
000345 (1998)	Maya Tsotsiashvilli [Israël] ; Raphael Levi [Israël] ; Ruth Arnon [Israël] ; Gideon Berke [Israël]	Activation of influenza-specific memory cytotoxic T lymphocytes by Concanavalin A stimulation
000346 (1982)	C. E. Mountford [Australie] ; G. Grossman [Australie] ; K. T. Holmes [Australie] ; W. J. O'Sullivan [Australie] ; A. W. Hampson [Australie] ; R. L. Raison [Australie] ; R. Webster [États-Unis]	Effect of monoclonal anti-neuraminidase antibodies on the kinetic behaviour of influenza virus neuraminidase
000370 (2003)	Susan J. Baigent [Royaume-Uni] ; John W. Mccauley [Royaume-Uni]	Influenza type A in humans, mammals and birds: Determinants of virus virulence, host‐range and interspecies transmission
000438 (1977)	Margaret Tisdale [Royaume-Uni] ; D. J. Bauer [Royaume-Uni]	THE RELATIVE POTENCIES OF ANTI‐INFLUENZA COMPOUNDS
000490 (1976)	Brian R. Murphy ; Douglas D. Richman ; Susan B. Spring ; Robert M. Chanock	Use of temperature-sensitive mutants of influenza A virus as live virus vaccine strains. Evaluation in laboratory animals, adults and children
000497 (1998)	Julia Serkedjieva [Bulgarie] ; Alan J. Hay [Royaume-Uni]	In vitro anti-influenza virus activity of a plant preparation from Geranium sanguineum L.
000551 (1994)	K. Scheepers [Allemagne] ; H. Becht [Allemagne]	Protection of mice against an influenza virus infection by oral vaccination with viral nucleoprotein incorporated into immunostimulating complexes

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "anti" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "anti" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    anti
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021